Aug 13, 2025 07:30AM
Aug 4, 2025 04:00PM
Aug 4, 2025 04:00PM
Jul 29, 2025 06:35AM
Jul 28, 2025 07:33AM
Jul 28, 2025 07:30AM
May 29, 2025 07:30AM Context Therapeutics to Appoint Dr. Karen Chagin, M.D. as Chief Medical Officer
May 13, 2025 07:30AM
Mar 26, 2025 06:57AM
Nov 13, 2024 04:05PM
Aug 12, 2024 07:00AM
May 15, 2024 07:30AM
Apr 23, 2024 02:00AM
Mar 6, 2024 07:00AM Adaptimmune Reports Q4/Full Year 2023 Financial Results and Business Updates
Nov 8, 2023 07:30AM
Sep 11, 2023 08:00AM
Aug 9, 2023 07:29AM
May 12, 2023 07:29AM
Mar 23, 2023 06:30AM
Mar 6, 2023 06:33AM
Mar 6, 2023 06:30AM Adaptimmune Reports Fourth-Quarter and Full Year Financial Results and Business Update
Mar 6, 2023 06:01AM
Mar 6, 2023 06:00AM
Mar 6, 2023 06:00AM
Mar 6, 2023 06:00AM
Feb 16, 2023 08:05AM
Feb 16, 2023 08:00AM
Nov 8, 2022 07:30AM Adaptimmune Reports Third-Quarter Financial Results and Business Update
Aug 4, 2022 07:30AM
Jun 15, 2022 07:00AM
May 9, 2022 07:30AM
Mar 17, 2022 07:30AM
Mar 14, 2022 08:00AM
Nov 4, 2021 07:30AM
Aug 9, 2021 04:00PM Adaptimmune Reports Second Quarter Financial Results and Business Update
May 6, 2021 07:30AM
Feb 25, 2021 07:30AM
Nov 5, 2020 07:30AM
Sep 15, 2020 09:27AM
Aug 6, 2020 07:30AM
Jun 4, 2020 10:45AM
Jun 2, 2020 05:52AM Adaptimmune Therapeutics (ADAP) Prices 20.5M ADS Offering at $11/ADS
Jun 1, 2020 09:38PM
Jun 1, 2020 06:12AM
Jun 1, 2020 06:00AM
May 14, 2020 07:30AM
Feb 27, 2020 07:30AM
Feb 7, 2020 04:05PM
Jan 24, 2020 04:30PM Adaptimmune Therapeutics plc Announces Closing of Public Offering of American Depositary Shares
Jan 22, 2020 08:49AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All